Sun Pharma Advanced Research Company Ltd (SPARC)
·Next Day Close·-3.08%·₹202.75
Key EventTrading window closure announced ahead of Q2 results
Sun Pharma Advanced Research Company Limited (SPARC)
·Next Day Close·-3.14%·₹197.7
Key EventSPARC applies to reclassify promoter shares to public category
Sun Pharma Advanced Research Company Limited (SPARC)
·Next Day Close·-1.42%·₹205.25
Key EventBoard approved Q1 FY26 financial results and promoter reclassification
ImpactThe company reported improved quarterly performance with narrower losses and revenue growth, while seeking regulatory approval for promoter reclassification.Sign up to read impact
Sun Pharma Advanced Research Company Limited (SPARC)
·Next Day Close·-1.42%·₹205.25
Key EventMonitoring Agency Report confirms no deviation in fund utilization for SPARC's preferential issue.
ImpactInvestors should note that fund utilization aligns with disclosures, indicating no material risks or changes in the planned use of proceeds.Sign up to read impact
Sun Pharma Advanced Research Company Limited (SPARC)
·Next Day Close·-1.42%·₹205.25
Key EventShareholders approved all AGM resolutions including CEO appointment and director retirement.
ImpactThe CEO appointment and PRV monetization strengthen financial flexibility and strategic focus on high-growth therapeutic areas.Sign up to read impact
Sun Pharma Advanced Research Company Limited (SPARC)
·Next Day Close·+1.8%·₹266.35
Sun Pharma Advanced Research Company Limited announced its 21st Annual General Meeting will be held on Monday, August 10, 2026 at 04:30 P.M. IST via Video Conference, with the 2025-26 Annual Report and voting instructions to be sent electronically to shareholders with updated contact details; the record date for eligibility to vote or attend is Monday, August 03, 2026.
Sign up to read summarySun Pharma Advanced Research Company Limited (SPARC)
·Next Day Close·+1.8%·₹266.35
Sun Pharma Advanced Research Company Limited (SPARC) received confirmation certificates from its share transfer agent, MUFG Intime India Private Limited, for the quarter ended June 30, 2026, under SEBI's Depositories and Participants Regulations, 2018. The certificates confirm dematerialized securities were accepted and listed on stock exchanges, with no rejections or cancellations reported during the period.
Sign up to read summarySun Pharma Advanced Research Company Limited (SPARC)
·Next Day Close·+3.07%·₹231.5
Sun Pharma Advanced Research Company Limited announced the retirement of Ms. Shanta Gupta and Dr. Nitin Dharmadhikari effective June 30, 2026, and the appointment of Mr. Prasanna Deshmukh as Functional Head – Human Resources & Administration from July 1, 2026, following SEBI Regulation 30 requirements.
Sign up to read summarySun Pharma Advanced Research Company Limited (SPARC)
·Next Day Close·+3.07%·₹231.5
Sun Pharma Advanced Research Company Limited (SPARC) announced termination of its license agreement with CMS Bridging DMCC effective June 25, 2026, stating no material impact on financial position or operations. The filing complies with SEBI LODR disclosure requirements for related party transactions.
Sign up to read summarySun Pharma Advanced Research Company Limited (SPARC)
·Next Day Close·-1.06%·₹224.6
Sun Pharma Advanced Research Company Limited announced that its trading window will close on July 1, 2026, ahead of unaudited quarterly results for the June 30 quarter, with the board meeting date to be disclosed later.
Sign up to read summary